The Future of Obesity Research

As seen at the American Diabetes Association annual conference, June 21-24, 2024!
There has been a paradigm shift in obesity care in the recent years:
• There is now a consensus about obesity being recognized as a treatable chronic disease, rather than a consequence of insufficient willpower,
• GLP-1 drugs are leading to unprecedented double digit weight loss.
However, there is still a high unmet need for compounds with complementary mode of action to the ones approved that can maximize weight loss but most importantly, can improve the quality of weight loss and long term weight maintenance.
To learn the key aspects of the future of obesity research, listen the discussion between Dr Filozof, VP and Therapy Area Head at Fortrea and Dr Eric Ravussin, from Pennington Research Center.
www.fortrea.com/about-us/even...
Dr Filozof and Fortrea colleagues will be present at ADA, reach out to schedule a meeting and discuss your obesity program.
#ADASciSessions #ClinicalResearch